RxDoctor Payments DataLook up a doctor →

Gwen Dalphon, PA

Medical · Newark, DENPI 1245574250

Payments from drug & device makers

$116,437in general payments, 2019–2025

Across 895 payments — averaging $130.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$66K
  • Galderma Laboratories, L.p.$27K
  • Johnson & Johnson$4K
  • Eli Lilly$4K
  • Regeneron Healthcare Solutions, Inc.$3K
  • Lilly USA, LLC$2K
  • plus $10K from 25 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$116,437 in reported general payments places this provider in the 95th percentile of 73 medical providers in Delaware.

See all medical providers in Delaware

Medicare billing

Part B allowed, 2024
$349,542
Medicare patients
841
Services billed
4,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →